Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Middelboe

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pharmacoepidemiology and Drug Safety|November 18, 2025
Titel: Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Treated With Immune Checkpoint Inhibitors Compared to Other Antineoplastic Medications: A Nationwide StudyIda M Heerfordt, Magnus Middelboe, Christian Kjer Heerfordt, et al.
The Journal of Dermatology|October 27, 2025
Toxic Epidermal Necrolysis and Mortality: A Danish Cohort Study With 30 Years of Follow-UpIda M Heerfordt, Magnus Middelboe, Ann Hærskjold, et al.
Scandinavian Journal of Medicine & Science in Sports|January 3, 2026
Healthcare Costs Associated With Anabolic Steroid Use: A Cohort StudyHenrik Horwitz, Renée Hangaard Olesen, Josefine Windfeld-Mathiasen, et al.
Diabetes, Obesity & Metabolism|November 10, 2025
Anabolic androgenic steroid use and risk of diabetes mellitus in malesFrederik Viggo Lautrup Esmann, Ida Marie Heerfordt, Josefine Windfeld-Mathiasen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pharmacoepidemiology and Drug Safety|November 18, 2025
Titel: Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Treated With Immune Checkpoint Inhibitors Compared to Other Antineoplastic Medications: A Nationwide StudyIda M Heerfordt, Magnus Middelboe, Christian Kjer Heerfordt, et al.
The Journal of Dermatology|October 27, 2025
Toxic Epidermal Necrolysis and Mortality: A Danish Cohort Study With 30 Years of Follow-UpIda M Heerfordt, Magnus Middelboe, Ann Hærskjold, et al.
Scandinavian Journal of Medicine & Science in Sports|January 3, 2026
Healthcare Costs Associated With Anabolic Steroid Use: A Cohort StudyHenrik Horwitz, Renée Hangaard Olesen, Josefine Windfeld-Mathiasen, et al.
Diabetes, Obesity & Metabolism|November 10, 2025
Anabolic androgenic steroid use and risk of diabetes mellitus in malesFrederik Viggo Lautrup Esmann, Ida Marie Heerfordt, Josefine Windfeld-Mathiasen, et al.
Pageof 1